| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027 | 1 | GlobeNewswire (USA) | ||
| Mo | Alignment Healthcare bounces back 7% after sharp prior-session drop | 1 | Seeking Alpha | ||
| ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| Mo | Alignment Healthcare sues CMS over its 2027 Medicare Advantage star ratings | 1 | FierceHealthcare | ||
| Mo | Alignment Healthcare USA, LLC: Alignment Health Launches New Medicare Advantage Plan Designed for Asian American Seniors in Los Angeles and Orange Counties | 1 | GlobeNewswire (USA) | ||
| Mo | TD Cowen senkt Kursziel für Alignment Healthcare wegen EBITDA-Sorgen | 2 | Investing.com Deutsch | ||
| Mo | TD Cowen cuts Alignment Healthcare stock price target on EBITDA concerns | 1 | Investing.com | ||
| Mo | UBS senkt Kursziel für Alignment Healthcare wegen Auslastungsdrucks drastisch | 1 | Investing.com Deutsch | ||
| Mo | UBS cuts Alignment Healthcare stock price target on utilization woes | 1 | Investing.com | ||
| Mo | Raymond James cuts Alignment Healthcare stock price target on star rating downgrade | 3 | Investing.com | ||
| Mo | Raymond James senkt Kursziel für Alignment Healthcare nach Herabstufung des Star-Ratings | 1 | Investing.com Deutsch | ||
| 10.10. | Alignment Healthcare downgraded at BofA after CMS Star Rating for MA contract | 4 | Seeking Alpha | ||
| 09.10. | Alignment Healthcare tumbles 13% to 52-week low | 2 | Seeking Alpha | ||
| 09.10. | Alignment Healthcare Stock Falls 17% On 2027 Medicare Star Ratings | 1 | RTTNews | ||
| 09.10. | BofA downgrades Alignment Healthcare stock rating on star rating drop | 4 | Investing.com | ||
| 09.10. | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | 1.209 | AFX News | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 09.10. | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | 5 | Investing.com Deutsch | ||
| 09.10. | William Blair downgrades Alignment Healthcare stock rating on cost pressures | 3 | Investing.com | ||
| 09.10. | Alignment Healthcare earns 4-Star or higher ratings for six plans | 3 | Investing.com | ||
| 08.10. | Alignment Healthcare Earns 4 Stars or Higher for Six of Seven Eligible Medicare Advantage Contracts in CMS 2027 Star Ratings | 2 | GlobeNewswire (USA) | ||
| 08.10. | Alignment Healthcare erhält hohe Medicare-Ratings, ficht aber wichtige Herabstufung an | 2 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,168 | +2,34 % | Teladoc Health, Inc.: Teladoc Health to Announce Third Quarter 2026 Financial Results | ||
| HIMS & HERS HEALTH | 24,740 | -0,96 % | Hims & Hers Health rises as HHS moves ahead with plan for compounding peptides | ||
| SERNOVA BIOTHERAPEUTICS | 0,065 | -7,91 % | ALARM bei Sernova Biotherapeutics Inc: Folgt jetzt der nächste Kursrutsch? - Dringend handeln! | ||
| CERENOME | 1,576 | +12,73 % | Cerenome, Inc.: Cerenome Launches CNSide CSF Molecular Profile Tests | HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announced the commercial launch... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,240 | -13,85 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 15,100 | +4,14 % | Tandem Diabetes Care Q2 2026 Earnings Call Transcript | ||
| CO-DIAGNOSTICS | 0,652 | -0,38 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 12,715 | +10,66 % | QuidelOrtho Reports Q2 2026 Results: Full Earnings Call Transcript | ||
| VERU | 2,310 | +0,43 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 6,030 | +0,50 % | 6,4 Millionen US-Dollar pro Patient: Warum Medtronic, Lifeward und NurExone an drei Stufen der Rückenmarksversorgung ansetzen | ||
| CLOVER HEALTH INVESTMENTS | 4,120 | +3,52 % | Why Is Clover Health (CLOV) Stock Soaring Today | ||
| SENSEONICS | 7,000 | +1,45 % | Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript | ||
| NANO-X IMAGING | 0,453 | -0,07 % | Nanox meldet vorläufigen Q3-Umsatz von bis zu $4,4 Millionen | ||
| TEMPEST THERAPEUTICS | 0,624 | 0,00 % | Tempest Therapeutics: Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise |